-+ 0.00%
-+ 0.00%
-+ 0.00%

MicroPort CardioFlow names Chen Guoming CEO, replacing Zhang Ruinian

PUBT·08/26/2026 14:58:09
Listen to the news
MicroPort CardioFlow names Chen Guoming CEO, replacing Zhang Ruinian
  • MicroPort CardioFlow Medtech named Guoming Chen chief executive, replacing Ruinian Zhang, effective Aug. 26, 2026.
  • Chen stepped down as board chair; previously served as chair since Aug. 2023, joined the group in 2016 leading R&D.
  • Brian Chang became board chair; he has been a non-executive director since Dec. 2025, chief medical officer at controlling shareholder MicroPort.
  • Zhang moved from chief executive to president; he remains an executive director.
  • Committee reshuffle: Chang joined the audit committee; Chen exited audit, joined nomination.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microport Cardioflow Medtech Corporation published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260826-12301443), on August 26, 2026, and is solely responsible for the information contained therein.